- Home
- ASRT vs SACH Comparison
ASRT vs SACH Comparison
Compare ASRT & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- SACH
- Stock Information
- Founded
- ASRT 1995
- SACH 2010
- Country
- ASRT United States
- SACH United States
- Employees
- ASRT N/A
- SACH N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- SACH Real Estate Investment Trusts
- Sector
- ASRT Health Care
- SACH Real Estate
- Exchange
- ASRT Nasdaq
- SACH Nasdaq
- Market Cap
- ASRT 57.9M
- SACH 61.5M
- IPO Year
- ASRT 1997
- SACH 2017
- Fundamental
- Price
- ASRT $0.74
- SACH $1.23
- Analyst Decision
- ASRT Strong Buy
- SACH Hold
- Analyst Count
- ASRT 2
- SACH 4
- Target Price
- ASRT $3.25
- SACH $2.25
- AVG Volume (30 Days)
- ASRT 244.1K
- SACH 199.5K
- Earning Date
- ASRT 08-06-2025
- SACH 08-05-2025
- Dividend Yield
- ASRT N/A
- SACH 16.26%
- EPS Growth
- ASRT N/A
- SACH N/A
- EPS
- ASRT N/A
- SACH N/A
- Revenue
- ASRT $119,001,000.00
- SACH N/A
- Revenue This Year
- ASRT N/A
- SACH N/A
- Revenue Next Year
- ASRT $11.91
- SACH $4.52
- P/E Ratio
- ASRT N/A
- SACH N/A
- Revenue Growth
- ASRT N/A
- SACH N/A
- 52 Week Low
- ASRT $0.51
- SACH $0.80
- 52 Week High
- ASRT $1.58
- SACH $2.75
- Technical
- Relative Strength Index (RSI)
- ASRT 61.81
- SACH 54.96
- Support Level
- ASRT $0.66
- SACH $1.14
- Resistance Level
- ASRT $0.79
- SACH $1.26
- Average True Range (ATR)
- ASRT 0.04
- SACH 0.06
- MACD
- ASRT 0.01
- SACH -0.01
- Stochastic Oscillator
- ASRT 64.29
- SACH 42.86
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.